InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Beaulieu Joseph, Autre. Insider active across 1 company, notably Epizyme, Inc.. Aggregated, 9 disclosures have been published. Split: 0 buy · 4 sells. Total volume traded: €2k. History available since 16 August 2021. The latest transaction was filed on 9 August 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
30,181 sharesCommon Stock, par value $0.0001SEC:0000899243-22-028859:0
300,000 shares@ US$1.3998.8% of flowCommon Stock, par value $0.0001SEC:0000899243-22-028418:0
2,331 shares@ US$1.266554.0% of flowCommon StockSEC:0000899243-22-011728:0
222 shares@ US$1.505.9% of flowCommon Stock, par value $0.0001SEC:0000899243-22-005473:0
222 shares@ US$1.500.1% of flowCommon Stock, par value $0.0001SEC:0000899243-22-005473
687 shares@ US$1.3717.1% of flowCommon Stock, par value $0.0001SEC:0000899243-22-004826:0
687 shares@ US$1.370.2% of flowCommon Stock, par value $0.0001SEC:0000899243-22-004826
14,833 shares0Common Stock, par value $0.0001SEC:0000899243-21-033404:0
14,833 shares0Common Stock, par value $0.0001SEC:0000899243-21-033404
9 of 9 declarations
About Beaulieu Joseph
Joseph Beaulieu is the Corporate Controller at Epizyme, Inc. His role is specified by remarks, highlighting his commitment to the company. His expertise and contributions are important for the development and strategy of Epizyme.
